Lykins Charmaine 4
4 · Karuna Therapeutics, Inc. · Filed Nov 30, 2021
Insider Transaction Report
Form 4
Lykins Charmaine
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-29+75,000→ 75,000 totalExercise: $125.52Exp: 2031-11-28→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]25% of this option shall vest on November 29, 2022, and the remaining 75% shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.